SCHEMBL27126227

SCHEMBL27126227

c1ccc2c(c1)ccc1c2oc2c(-c3ccc4ccc5cccc6ccc3c4c56)ccc(-c3ccc4ccc5cccc6ccc3c4c56)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.42
ERBB2 P04626 1/20 0.42
FYN P06241 1/20 0.42
MAOA P21397 1/20 0.42
ACHE P22303 1/20 0.42
AHR P35869 1/20 0.42
ARSA P15289 1/20 0.42
CDC25A P30304 1/20 0.42
CDC25C P30307 1/20 0.42
HPGD P15428 6/20 0.41
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 4/20 0.41
THRB P10828 1/20 0.41
CYP1A1 P04798 5/20 0.40
CYP1B1 Q16678 5/20 0.40
KDM4E B2RXH2 4/20 0.40
CYP3A4 P08684 3/20 0.40
TSHR P16473 3/20 0.40
ABCG2 Q9UNQ0 2/20 0.40
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27127221 1.00 CYP1A2 (0.42) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL27126291 0.97 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL27126211 0.97 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL27127212 0.97 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL27126249 0.96 CYP1A2 (0.46) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL27126222 0.96 CYP1A2 (0.42) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL27126330 0.96 CYP1A2 (0.46) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL27126297 0.96 CYP1A2 (0.42) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL27127041 0.96 ARSA (0.45) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL27127385 0.94 CYP1A2 (0.43) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-02-29 US disclosed
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-02-29 US disclosed
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-02-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE RPS12, TCF12, RRP12 CYP1A2 966/4885ERBB2 3208/4885FYN 3541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.